Perspective Therapeutics
Website to be confirmed.
About Perspective Therapeutics
A Radiopharma Developer player with a presence on the SNMMI floor; commercial activity worth a closer look.
Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.
What we're seeing
- PR Newswire · 2026-10-27Perspective Therapeutics announces Phase II readout for lead theranostic candidateCoverage notes the company's growing footprint in the radioligand therapy space.
- Nuclear Medicine Today · 2026-05-16Perspective Therapeutics expands cyclotron capacity to meet Lu-177 demandThe work builds on more than a decade of radiochemistry collaboration.
- STAT News · 2026-12-25Perspective Therapeutics signs supply agreement to support late-stage trialsCoverage notes the company's growing footprint in the radioligand therapy space.
Mocked while we wire the Exa integration. Headlines are illustrative.
What we expect to see at the booth
Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.
A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.
Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.
Companies you may also want to visit.
Actinium Pharmaceuticals
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Actinium Pharmaceuticals.
View profile →AtomVie Global Radiopharma Inc.
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on AtomVie Global Radiopharma Inc..
View profile →Bayer Oncology
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Bayer Oncology.
View profile →